Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) that require fluorinated aromatic structures for enhanced metabolic stability and bioavailability. Its bromo and trifluoromethyl functional groups allow for selective cross-coupling reactions, making it valuable in medicinal chemistry for constructing complex molecules. Also employed in the preparation of agrochemicals and specialty materials where halogenated and fluorinated moieties improve performance characteristics such as lipophilicity and resistance to degradation.